Alembic Pharmaceuticals Ltd. | Mid-cap | Healthcare
₹968.90
-0.58%
| Alembic Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 66.7B
Gross Profit 48.8B 73.12%
Operating Income 7.3B 10.94%
Net Income 5.8B 8.72%
EPS (Diluted) ₹29.68

Balance Sheet Metrics

Total Assets 77.7B
Total Liabilities 25.8B
Shareholders Equity 51.9B
Debt to Equity 0.50

Cash Flow Metrics

Operating Cash Flow -3.1B
Free Cash Flow -4.8B

Revenue & Profitability Trend

Alembic Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 66.7B 61.1B 55.0B 52.3B 52.8B
Cost of Goods Sold 17.9B 20.0B 20.2B 17.2B 15.2B
Gross Profit 48.8B 41.1B 34.8B 35.1B 37.5B
Operating Expenses 23.1B 18.5B 17.4B 15.7B 13.4B
Operating Income 7.3B 6.6B 4.4B 5.9B 13.0B
Pre-tax Income 7.1B 6.3B 3.5B 6.3B 13.7B
Income Tax 1.3B 160.0M 126.1M 1.0B 2.5B
Net Income 5.8B 6.2B 3.4B 5.2B 11.5B
EPS (Diluted) ₹29.68 ₹31.33 ₹17.40 ₹26.50 ₹59.18

Income Statement Trend

Alembic Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 40.9B 30.8B 29.1B 28.6B 26.5B
Non-Current Assets 36.9B 33.7B 32.7B 42.6B 40.6B
Total Assets 77.7B 64.5B 61.8B 71.2B 67.1B
Liabilities
Current Liabilities 23.9B 14.6B 16.4B 17.2B 12.8B
Non-Current Liabilities 1.9B 1.7B 1.8B 1.7B 3.6B
Total Liabilities 25.8B 16.3B 18.1B 18.8B 16.4B
Equity
Total Shareholders Equity 51.9B 48.2B 43.7B 52.4B 50.7B

Balance Sheet Composition

Alembic Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 7.1B 6.3B 3.5B 6.3B 13.7B
Operating Cash Flow -3.1B 5.4B 4.6B 3.0B 15.5B
Investing Activities
Capital Expenditures -5.6B -3.2B -4.4B -4.3B -6.6B
Investing Cash Flow -5.7B -3.2B -4.5B -3.8B -8.5B
Financing Activities
Dividends Paid -2.2B -1.6B -2.0B -2.8B -
Financing Cash Flow 5.5B -3.6B -1.9B -1.5B -5.1B
Free Cash Flow -4.8B 4.8B 2.8B 1.3B 8.0B

Cash Flow Trend

Alembic Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.62
Forward P/E 21.60
Price to Book 3.56
Price to Sales 2.79
PEG Ratio 21.60

Profitability Ratios

Profit Margin 8.74%
Operating Margin 11.48%
Return on Equity 11.63%
Return on Assets 6.42%

Financial Health

Current Ratio 1.70
Debt to Equity 24.23
Beta 0.50

Per Share Data

EPS (TTM) ₹29.72
Book Value per Share ₹264.09
Revenue per Share ₹339.44

Financial data is updated regularly. All figures are in the company's reporting currency.